The results of BIOCARD Research Team show that the expression level of NPTX2 in mild cognitive impairment (MCI) is significantly lower than that of normal people, and NPTX2 may participate in the regulation of cognitive tasks in MCI (Soldan et al., 2019). Here, NPTX2 is linked to Cognitive impairment.